MedTrace Logo

Blood Glucose Response of Novel Wild Rice Enhanced Food Products (Trial 1)

NCT06497972 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2025-08-24

No results posted yet for this study

Summary

The goal of this acute double-blind cross over trial is to test the effects of a wild rice cake product compared to products currently on the market on glycaemic control. The main questions it aims to answer are:

1. What is the effect compared to products currently on the market on glycaemic control?
2. Is the wild rice product palatable?

Participants will:

* consent to attend 4 study visits being 2.5 hours each
* come to each visit fasted for at least 10-12 hours.
* complete a Motivation to Eat VAS following each blood measure

Conditions

  • Blood Glucose

Interventions

OTHER

White bread (control, 32 grams, 14.4 grams of carbohydrate)

32 grams of white bread, providing 14.4 grams of carbohydrate, which was incorrectly dosed and matched only half the carbohydrate in the rice cakes.

OTHER

Brown rice cake

A 40g rice cake made of 100% brown rice (providing 31 grams of carbohydrate)

OTHER

Wild rice (25%) and brown rice (75%) cake

A 40g rice cake made of a blend of 25% wild rice and 75% brown rice (providing 31 grams of carbohydrate)

OTHER

White bread (control, 66 grams, 31 grams of carbohydrate)

66 grams of white bread, providing 31 grams of carbohydrate, this arm was added after the mistake in the first control dosing was discovered, so this arm was not randomized and was completed after the first three.

Sponsors & Collaborators

  • Dylan MacKay

    lead OTHER

Principal Investigators

  • Dylan MacKay, PHD · University of Manitoba

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-05
Primary Completion
2025-04-18
Completion
2025-04-18

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06497972 on ClinicalTrials.gov